IRF2 and neoplasm: To confirm whether tumor hepatocytes could be mediating IRF2 and POU2F1 downstream signaling to influence immune response, we investigated Irf2 and Pou2f1 expression in both human and mouse liver scRNA-seq datasets36 (GSE192742).